1. Home
  2. EVO vs PWP Comparison

EVO vs PWP Comparison

Compare EVO & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • PWP
  • Stock Information
  • Founded
  • EVO 1993
  • PWP 2006
  • Country
  • EVO Germany
  • PWP United States
  • Employees
  • EVO N/A
  • PWP N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • PWP Finance: Consumer Services
  • Sector
  • EVO Health Care
  • PWP Finance
  • Exchange
  • EVO Nasdaq
  • PWP Nasdaq
  • Market Cap
  • EVO 1.4B
  • PWP 1.4B
  • IPO Year
  • EVO 2021
  • PWP N/A
  • Fundamental
  • Price
  • EVO $3.97
  • PWP $17.37
  • Analyst Decision
  • EVO Buy
  • PWP Hold
  • Analyst Count
  • EVO 2
  • PWP 3
  • Target Price
  • EVO $5.90
  • PWP $23.00
  • AVG Volume (30 Days)
  • EVO 201.5K
  • PWP 1.0M
  • Earning Date
  • EVO 05-06-2025
  • PWP 05-02-2025
  • Dividend Yield
  • EVO N/A
  • PWP 1.61%
  • EPS Growth
  • EVO N/A
  • PWP N/A
  • EPS
  • EVO N/A
  • PWP N/A
  • Revenue
  • EVO $851,944,444.00
  • PWP $987,743,000.00
  • Revenue This Year
  • EVO $10.08
  • PWP $5.79
  • Revenue Next Year
  • EVO $10.99
  • PWP $18.31
  • P/E Ratio
  • EVO N/A
  • PWP N/A
  • Revenue Growth
  • EVO 1.50
  • PWP 59.48
  • 52 Week Low
  • EVO $2.84
  • PWP $13.82
  • 52 Week High
  • EVO $5.64
  • PWP $27.03
  • Technical
  • Relative Strength Index (RSI)
  • EVO 48.96
  • PWP 45.06
  • Support Level
  • EVO $3.78
  • PWP $17.11
  • Resistance Level
  • EVO $4.80
  • PWP $18.18
  • Average True Range (ATR)
  • EVO 0.14
  • PWP 0.85
  • MACD
  • EVO -0.04
  • PWP -0.10
  • Stochastic Oscillator
  • EVO 18.63
  • PWP 9.67

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About PWP Perella Weinberg Partners

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.

Share on Social Networks: